These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 21352605)

  • 1. Transport characteristics of guanidino compounds at the blood-brain barrier and blood-cerebrospinal fluid barrier: relevance to neural disorders.
    Tachikawa M; Hosoya K
    Fluids Barriers CNS; 2011 Feb; 8(1):13. PubMed ID: 21352605
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Creatine and guanidinoacetate transport at blood-brain and blood-cerebrospinal fluid barriers.
    Braissant O
    J Inherit Metab Dis; 2012 Jul; 35(4):655-64. PubMed ID: 22252611
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The blood-brain barrier transport and cerebral distribution of guanidinoacetate in rats: involvement of creatine and taurine transporters.
    Tachikawa M; Kasai Y; Yokoyama R; Fujinawa J; Ganapathy V; Terasaki T; Hosoya K
    J Neurochem; 2009 Oct; 111(2):499-509. PubMed ID: 19682207
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Roles of organic anion/cation transporters at the blood-brain and blood-cerebrospinal fluid barriers involving uremic toxins.
    Hosoya K; Tachikawa M
    Clin Exp Nephrol; 2011 Aug; 15(4):478-85. PubMed ID: 21611756
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression and possible role of creatine transporter in the brain and at the blood-cerebrospinal fluid barrier as a transporting protein of guanidinoacetate, an endogenous convulsant.
    Tachikawa M; Fujinawa J; Takahashi M; Kasai Y; Fukaya M; Sakai K; Yamazaki M; Tomi M; Watanabe M; Sakimura K; Terasaki T; Hosoya K
    J Neurochem; 2008 Nov; 107(3):768-78. PubMed ID: 18761709
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Processing mechanism of guanidinoacetate in choroid plexus epithelial cells: conversion of guanidinoacetate to creatine via guanidinoacetate N-methyltransferase and monocarboxylate transporter 12-mediated creatine release into the CSF.
    Jomura R; Akanuma SI; Kubo Y; Tachikawa M; Hosoya KI
    Fluids Barriers CNS; 2022 Jun; 19(1):42. PubMed ID: 35658878
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular biology of the blood-brain and the blood-cerebrospinal fluid barriers: similarities and differences.
    Redzic Z
    Fluids Barriers CNS; 2011 Jan; 8(1):3. PubMed ID: 21349151
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A role for guanidino compounds in the brain.
    Hiramatsu M
    Mol Cell Biochem; 2003 Feb; 244(1-2):57-62. PubMed ID: 12701810
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SLC and ABC Transporters: Expression, Localization, and Species Differences at the Blood-Brain and the Blood-Cerebrospinal Fluid Barriers.
    Morris ME; Rodriguez-Cruz V; Felmlee MA
    AAPS J; 2017 Sep; 19(5):1317-1331. PubMed ID: 28664465
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New aspects of the blood-brain barrier transporters; its physiological roles in the central nervous system.
    Ohtsuki S
    Biol Pharm Bull; 2004 Oct; 27(10):1489-96. PubMed ID: 15467183
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Physiological function of blood-brain barrier transporters as the CNS supporting and protecting system].
    Ohtsuki S
    Yakugaku Zasshi; 2004 Nov; 124(11):791-802. PubMed ID: 15516806
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of cationic drug-sensitive transport systems at the blood-cerebrospinal fluid barrier in para-tyramine elimination from rat brain.
    Akanuma SI; Yamazaki Y; Kubo Y; Hosoya KI
    Fluids Barriers CNS; 2018 Jan; 15(1):1. PubMed ID: 29307307
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potential role of ABC transporters as a detoxification system at the blood-CSF barrier.
    de Lange EC
    Adv Drug Deliv Rev; 2004 Oct; 56(12):1793-809. PubMed ID: 15381334
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Astrocytic γ-aminobutyric acid (GABA) transporters mediate guanidinoacetate transport in rat brain.
    Tachikawa M; Yashiki A; Akanuma SI; Matsukawa H; Ide S; Minami M; Hosoya KI
    Neurochem Int; 2018 Feb; 113():1-7. PubMed ID: 29175673
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Renal handling of guanidino compounds in rat and rabbit.
    Levillain O; Marescau B; De Deyn PP
    J Physiol; 1997 Mar; 499 ( Pt 2)(Pt 2):561-70. PubMed ID: 9080382
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Guanidino compounds in guanidinoacetate methyltransferase deficiency, a new inborn error of creatine synthesis.
    Stöckler S; Marescau B; De Deyn PP; Trijbels JM; Hanefeld F
    Metabolism; 1997 Oct; 46(10):1189-93. PubMed ID: 9322805
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Involvement of Carrier-Mediated Transport at the Blood-Cerebrospinal Fluid Barrier in Spermine Clearance from Rat Brain.
    Akanuma SI; Shimada H; Kubo Y; Hosoya KI
    Biol Pharm Bull; 2017; 40(9):1599-1603. PubMed ID: 28867747
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacological significance of prostaglandin E2 and D2 transport at the brain barriers.
    Tachikawa M; Hosoya K; Terasaki T
    Adv Pharmacol; 2014; 71():337-60. PubMed ID: 25307222
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Multi-disciplinary research approaches on the brain barrier transport system, a dynamic interface].
    Tachikawa M; Uchida Y; Terasaki T
    Brain Nerve; 2013 Feb; 65(2):121-36. PubMed ID: 23399670
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression Profiling of Solute Carrier Gene Families at the Blood-CSF Barrier.
    Ho HT; Dahlin A; Wang J
    Front Pharmacol; 2012; 3():154. PubMed ID: 22936914
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.